Categories: DNANews

Sequentify Announces Research Grants for High-Throughput Genomic Studies

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

REHOVOT, Israel, April 17, 2025 /PRNewswire/ — Sequentify is offering research grants to accelerate high-impact genomic studies through its uniquely fast, easy-to-use, and scalable targeted library preparation technology. Designed to enable the widespread adoption of high-throughput genomic testing, Sequentify’s protocol is ideal for large-scale programs conducting targeted sequencing at the population or cohort level.

We invite proposals from research groups conducting genomic DNA studies using human-derived samples, regardless of research field. Eligible areas include, but are not limited to: oncology, rare disease, reproductive health, infectious disease, population screening, and public health.

 To qualify, proposed studies must:

  • Involve 5,000 human samples or more
  • Require Sequentify’s off-the-shelf or customized panels (up to 10,000 genomic targets)

Selected applicants will receive:

  • Reagents for up to 10,000 samples
  • Access to Sequentify’s end-to-end analysis software

Submission Guidelines: In up to 250 words, describe how this grant would enhance your research and contribute to your scientific field.

Application period: April 5 – June 20, 2025

Submit applications to: hello@sequentify.com 

If you have questions about the grant or your project’s eligibility, feel free to reach out to us at the same address—we’d be happy to help.

About Sequentify:

Founded in 2021 as a Weizmann Institute spinoff, Sequentify enables decentralized, population-wide genomic sequencing by providing laboratories with the easiest and quickest solutions available. Their technology facilitates the scaling-up of genomic testing by directly addressing the current pain points in the industry, through sample-prep and software solutions. The company offers panels for oncology and screening applications, and infectious diseases, with a focus on the clinical market. Sequentify is based in Rehovot, Israel. For more information about the company, visit https://www.sequentify.com/.

Media Contact:
Avigayil Simpson
avigayil@sequentify.com

Logo: https://healthtechnologynet.com/wp-content/uploads/2025/04/SEQUENTIFY_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/sequentify-announces-research-grants-for-high-throughput-genomic-studies-302431271.html

SOURCE Sequentify

Staff

Recent Posts

Rapid Dose Announces Proposed Debt Settlement

Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…

9 hours ago

HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES QUARTERLY DIVIDEND INCREASE

GLEN ALLEN, Va., May 9, 2025 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB) (the…

10 hours ago

Auguste Escoffier School of Culinary Arts Earns Great Place To Work-Certified™ Status for Sixth Consecutive Year

SCHAUMBURG, Ill., May 9, 2025 /PRNewswire/ -- For the sixth year in a row, Auguste…

10 hours ago

Dr. Christina Rahm’s Merci Dupre Clothiers Presents Revolutionary Eco-Fashion Show Tonight in Spartanburg, SC

Spartanburg, South Carolina--(Newsfile Corp. - May 9, 2025) - Dr. Christina Rahm, renowned scientist, humanitarian,…

13 hours ago

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one…

15 hours ago